Aichi Cancer Center
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 · Yung‐Jue Bang, Eric Van Cutsem, et al. · The Lancet
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
2005 · Martine Piccart, Marion Procter, et al. · New England Journal of Medicine
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
2011 · William D. Travis, Élisabeth Brambilla, et al. · Journal of Thoracic Oncology